Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Ventilated vacuum communication structure
Modular storage system
Printing device, printing system, program, and printing method for printing based on print data from a user authorized to issue a print instruction for the print data
Process for preparing MDA via the stage of the aminal
Prevention and reduction of blood loss
Method of fabricating CIGS by selenization at high temperature
Endotracheal tube
  Randomly Featured Patents
Adjustable check valve for use in an oxygen regulator
Turnable tractor vehicle having fixed axle
Method and system for calculating a local time for a user equipment in an intelligent network
Method for producing a fiber optic switch
Dispenser for rolled tissue and the like
Die assembly and a method of making it
Shut-off screw
Connector assembly
Methods of treatment with compounds having RAR.alpha. receptor specific or selective activity
Post driving device